Evidence map›Paper›PMID 29559929›Full record

ArticleFrontiers in psychiatry2018

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder.

Azmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, Yi-Hsiang Hsu, Katrin Sangkuhl, Gregory Jenkins, Ryan M Whaley, Poulami Barman, Anthony Batzler, Russ B Altman and 27 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Integrating multi-polygenic scores for enhanced prediction of antidepressant treatment outcomes in an East Asian population.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Greenness, Genetic Predisposition, and Tinnitus.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. The promise of machine learning in predicting treatment outcomes in psychiatry.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 7 countries.

Azmeraw T AmareDiscipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
Klaus Oliver SchubertDiscipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
Fasil Tekola-AyeleEpidemiology Branch, Division of Intramural Population Health Research, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States.
Yi-Hsiang HsuHSL Institute for Aging Research, Harvard Medical School, Boston, MA, United States.
Katrin SangkuhlBiomedical Data Science, Stanford University, Stanford, CA, United States.
Gregory JenkinsDepartment of Health Sciences Research, Mayo Clinic, Rochester, NY, United States.
Ryan M WhaleyBiomedical Data Science, Stanford University, Stanford, CA, United States.
Poulami BarmanDepartment of Health Sciences Research, Mayo Clinic, Rochester, NY, United States.
Anthony BatzlerDepartment of Health Sciences Research, Mayo Clinic, Rochester, NY, United States.
Russ B AltmanDepartment of Bioengineering, Stanford University, Stanford, CA, United States.
Volker AroltDepartment of Psychiatry and Psychotherapy, University of Muenster, Muenster, Germany.
Jürgen BrockmöllerDepartment of Clinical Pharmacology, University Göttingen, Göttingen, Germany.
Chia-Hui ChenDepartment of Psychiatry, Taipei Medical University-Shuangho Hospital, New Taipei City, Taiwan.
Katharina DomschkeDepartment of Psychiatry and Psychotherapy, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Daniel K Hall-FlavinDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, NY, United States.
Chen-Jee HongDepartment of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
Ari IlliDepartment of Psychiatry, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Yuan JiDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Rochester, Rochester, MN, United States.
Olli KampmanDepartment of Psychiatry, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Toshihiko KinoshitaDepartment of Neuropsychiatry, Kansai Medical University, Osaka, Japan.
Esa LeinonenDepartment of Psychiatry, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Ying-Jay LiouDepartment of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
Taisei MushirodaRIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
Shinpei NonenDepartment of Pharmacy, Hyogo University of Health Sciences, Hyogo, Japan.
Michelle K SkimeDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, NY, United States.
Liewei WangDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Rochester, Rochester, MN, United States.
Masaki KatoDepartment of Neuropsychiatry, Kansai Medical University, Osaka, Japan.
Yu-Li LiuCenter for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan.
Verayuth PraphanphojCenter for Medical Genetics Research, Rajanukul Institute, Department of Mental Health, Ministry of Public Health Bangkok, Bangkok, Thailand.
Julia C StinglResearch Division Federal Institute for Drugs and Medical Devices, Bonn, Germany.
William V BoboDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, NY, United States.
Shih-Jen TsaiDepartment of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
Michiaki KuboRIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
Teri E KleinBiomedical Data Science, Stanford University, Stanford, CA, United States.
Richard M WeinshilboumDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Rochester, Rochester, MN, United States.
Joanna M BiernackaDepartment of Health Sciences Research, Mayo Clinic, Rochester, NY, United States.
Bernhard T BauneDiscipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
Mayo Clinic · USMayo Clinic in Florida · USStanford University · USUniversity of Adelaide · AUKansai Medical University · JPRIKEN Center for Integrative Medical Sciences · JPTaipei Veterans General Hospital · TWFederal Institute for Drugs and Medical Devices · DEHebrew SeniorLife · USHyogo University of Health Sciences · JPMinistry of Public Health · THNational Health Research Institutes · TWNational Institutes of Health · USNational Yang Ming Chiao Tung University · TWSeinäjoki University of Applied Sciences · FITaipei Medical University-Shuang Ho Hospital · TWTampere University · FITampere University Hospital · FIUniversity of Freiburg · DEUniversity of Göttingen · DE

Funding

PharmGKB: pharmacogenomics knowledge for precision medicineR24GM061374 · NIGMS · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO, KLEIN, TERI ELLEN · 2010 to 2018
$25.2M
Pharmacogenetics of Phase II Drug Metabolizing EnzymesU19GM061388 · NIGMS · MAYO CLINIC ROCHESTER · PI WANG, LIEWEI, WEINSHILBOUM, RICHARD M. · 2010 to 2014
$15.8M
Osteocalcin and Metabolic Risk Factors. The Framingham StudyR21AR056405 · NIAMS · HEBREW REHABILITATION CENTER FOR AGED · PI HSU, YI-HSIANG · 2010 to 2011
$377k
NIAMS NIH HHS R21 AR056405NIGMS NIH HHS R24 GM061374NIGMS NIH HHS U19 GM061388
6 · The paper itself

Abstract

Studies reported a strong genetic correlation between the Big Five personality traits and major depressive disorder (MDD). Moreover, personality traits are thought to be associated with response to antidepressants treatment that might partly be mediated by genetic factors. In this study, we examined whether polygenic scores (PGSs) derived from the Big Five personality traits predict treatment response and remission in patients with MDD who were prescribed selective serotonin reuptake inhibitors (SSRIs). In addition, we performed meta-analyses of genome-wide association studies (GWASs) on these traits to identify genetic variants underpinning the cross-trait polygenic association. The PGS analysis was performed using data from two cohorts: the Pharmacogenomics Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS,

Indexed as

antidepressantsmajor depressionpersonality traitspharmacogenomicspolygenic scoreselective serotonin reuptake inhibitors

Identifiers

PMID29559929
PMCPMC5845551
OpenAlexW2790681850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.